Bunge Stock Could $134 by Year End, JPMorgan Analyst Says
JPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
JPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
Capital One’s stock sits near $184 after a wave of acquisitions and an earnings miss. Here’s what Wall Street expects...
As money flows into SPY accelerate, four small-cap ETFs are quietly delivering outsized gains. This report breaks dow...
Unconfirmed reports حول the health status of billionaire founder leonid spark talk of leadership changes at OnlyFans’...
GOP-led statehouses are intensifying limits on abortion pills, while a new survey links telehealth-based pill use to ...
The Philippines moved to shield households from rising energy costs after the Middle East conflict intensified, decla...
TD Cowen warns that bills advancing prediction markets face a tough path in Congress this year, citing bipartisan con...
Bitcoin built on recent gains as macro risk appetite improved and liquidity returned, setting the stage for a test of...
A new anti-spam proposal at the heart of Bitcoin’s governance debate has sparked a power struggle, with analysts ques...
A Santa Monica jury ruled Bill Cosby liable for a 1972 assault, awarding $59.25 million in total damages, including $...
A late-2025 Gallup poll finds only 28% of workers say now is a good time to find a quality job, with broad caution do...
In Florida, trump hates voting mail—except, as ballots are cast, the president shows a paradox that highlights the po...